Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00806260 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate How VI-0521 Affect Psychomotor Performance in Healthy Overweight and Obese Subjects.
A Phase 2 study, sponsored by VIVUS.
- Completed
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
NCT00806260 is a Phase 2 study that has completed, run by VIVUS. The registered enrollment target is 80 participants.
The verdict
NCT00806260, a Phase 2 study, has completed, sponsored by VIVUS.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how VI-0521 affect speed and reaction time on specific tasks that require eye and hand coordination, compared to placebo.
Interventions
- DRUG Placebo
- OTHER Alcohol
- DRUG VI-0521
- OTHER alcohol placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00806260
The ClinicalTrials.gov registry entry for NCT00806260 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VIVUS, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00806260 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00806260 about?
NCT00806260 is a clinical study titled "A Study to Evaluate How VI-0521 Affect Psychomotor Performance in Healthy Overweight and Obese Subjects.". The purpose of this study is to determine how VI-0521 affect speed and reaction time on specific tasks that require eye and hand coordination, compared to placebo.
What is the current status of trial NCT00806260?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2008-12. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00806260?
The interventions under investigation include: Placebo (DRUG), Alcohol (OTHER), VI-0521 (DRUG), alcohol placebo (OTHER).
Who is sponsoring clinical trial NCT00806260?
This trial is sponsored by VIVUS, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.